OREANDA-NEWS. Association of International Pharmaceutical Manufacturers announced its expansion. General meeting of the AIPM members held on March 21, 2013 admitted the R-Pharm Group as a new member of the Association. This is an important milestone for Russian pharmaceutical market showing the irreversibility of cooperation and integration processes between Russian and International pharmaceutical companies.

Global integration is a trend of today for pharmaceutical industry. Some drugs are manufactured in one country and then being distributed around the globe, while the others are truly international by its nature because their steps of R&D and manufacturing are conducted in various countries. It’s a pleasure to see that Russia actively participates in this process having the R-Pharm Group among the leaders.

“AIPM follow consistent policy in terms of cooperation with Russian companies ready to comply with international standards. The Association is happy to greet the R-Pharm Group as a new member. This company has a long-term strategy for R&D, manufacturing and distribution of contemporary pharmaceutical products and ready to cooperate with leading international manufacturers. We believe that having R-Pharm as a member of our Association will help to reach our common goal – to improve accessibility of contemporary high quality therapy for Russian citizens,” said Vladimir Shipkov, CEO, Association of International Pharmaceutical Manufacturers (AIPM).

“We are excited to become a member of AIPM and looking forward for efficient and long-term cooperation in compliance with ethic principles of the Association. International partnership is one of the key priorities for R-Pharm. We have several partnership agreements with leading international pharmaceutical companies and organizations covering drug development and clinical trials. I hope that our membership in AIPM will help to improve Russian healthcare system and make the most efficient pharmaceutical products available to Russian patients,” said Alexey Repik, Chairman, The R-Pharm Group.

Additional information: Association of International Pharmaceutical Manufacturers (AIPM) unites over 50 international companies responsible for over 80% of global pharmaceutical manufacturing and over 60% of drugs imported to Russian Federation.

JSC R-Pharm is one of the largest Russian pharmaceutical companies. The company has 36 branches and offices across Russia offering jobs for over 2500 employees. The company is focused on R&D, manufacturing and distribution of various pharmaceutical products mostly for hospitals and special kinds of treatment. Key areas of R-Pharm’s competence include: manufacturing of finished drugs, chemical APIs and biotechnical substances, R&D of innovative medicines and technologies, marketing of contemporary highly efficient drugs, and training of industry and health care specialists.